69022-52-2

Usage

Uses

Used in Organic Synthesis:
2,5-Dimethyl-3-nitrobenzaldehyde is used as an intermediate in the production of various pharmaceuticals, agrochemicals, and dyes. Its unique structure allows it to be a key component in the synthesis of a wide range of organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,5-Dimethyl-3-nitrobenzaldehyde is used as a building block for the development of new drugs. Its reactivity and functional groups make it a valuable precursor in the synthesis of medicinal compounds.
Used in Agrochemical Industry:
2,5-Dimethyl-3-nitrobenzaldehyde is utilized as an intermediate in the synthesis of agrochemicals, contributing to the development of pesticides and other agricultural chemicals that are essential for crop protection and yield enhancement.
Used in Dye Industry:
2,5-Dimethyl-3-nitrobenzaldehyde is also used in the dye industry for the production of various dyes, where its chemical properties allow for the creation of a diverse range of colorants used in textiles, plastics, and other materials.
Used in Fine Chemicals Preparation:
2,5-Dimethyl-3-nitrobenzaldehyde is employed in the preparation of fine chemicals, which are high-purity chemicals used in various applications, including research, pharmaceuticals, and specialty industries.
Used in Research Laboratories:
In research laboratories, 2,5-Dimethyl-3-nitrobenzaldehyde serves as a reagent for conducting experiments and exploring new chemical reactions and synthesis pathways, furthering scientific knowledge and innovation in the field of chemistry.

Upstream product

• 100-97-0 hexamethylenetetramine 
• 18102-22-2 1-(chloromethyl)-2,5-dimethyl-3-nitrobenzene 
• 7790-94-5 chlorosulfonic acid 
• 50-00-0 formaldehyd 
• 89-58-7 mononitro-p-xylene 
• 13730-55-7 methyl 2,5-dimethylbenzoate 

Downstream Products

• 1598417-85-6 4-(2,5-dimethyl-3-nitro-benzylamino)-piperidine-1-carboxylic acid tert-butyl ester 
• 1598417-11-8 4-(2-(4-(2,5-dimethyl-3-nitrobenzylamino)piperidin-1-yl)ethyl)-6-methoxyquinoline-3-carbonitrile 
• 69022-56-6 3-acetamido-2,5-dimethylcinnamoyl azide 
• 69022-55-5 3-acetamido-2,5-dimethylcinnamic acid 
• 85430-26-8 alcool dimethyl-2,5 hydroxy-3 benzylique 
• 69022-53-3 trans-2,5-dimethyl-3-nitrocinnamic acid 
• 98447-23-5 dimethyl-2,5 nitro-3 benzaldehyde dimethylacetal 

Relevant academic research and scientific papers

HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA

The present invention relates to a compound according to general formula (I) wherein X represents N or CH; R1 is -CN, (C1-C6)alkyl, (C3-C7)cycloalkyl, (3-7 membered)heterocycloalkyl, (5-6 membered)heteroaryl, (C3-C7)cycloalkyl(C1-C4)alkyl, (3-7 membered)heterocycloalkyl-(C1-C4)alkyl or (5-6 membered)heteroaryl- (C1-C4)alkyl; R2 is halogen, cyano, (C1-C4)alkyl or (C3-C7)cycloalkyl; R3 is halogen, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl or (C3-C7)cycloalkyl; R4 is (C1-C4)alkyl or (C1-C4)haloalkyl; R5 is (C1-C6)alkyl, (C3-C7)cycloalkyl, (C1-C6)alkyl-(C3-C7)cycloalkyl, (C3-C7)cycloalkyl-(C1-C6)alkyl, (3-7 membered)heterocycloalkyl, phenyl, (5-6 membered)heteroaryl or -ORa. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds and to intermediates for preparation of said compounds.

Synthesis and activity of a novel inhibitor of nonsense-mediated mRNA decay

During efforts to prepare the known compound NMDI1, a new tetracyclic compound, called VG1, was prepared in six steps. This compound was found to have good activity as an inhibitor of nonsense-mediated mRNA decay.

INHIBITORS OF DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS

The present invention relates to compounds which specifically inhibit bacterial DNA Gyrase and can be used for the treatment of respiratory tract infections.

4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use

Compounds of formula I are useful in treating diseases prevented by or ameliorated with α1A agonists. Also disclosed are α1A agonist compositions and a method of activating α1 adrenoceptors in a mammal.

Dipyrido [4,3-b] [3,4-f] indoles and process for obtaining them

The invention relates to compounds of formula: STR1 wherein R'1 =H, OH or an alkyl group, preferably a lower alkyl group, alkylthio or alkoxy, an halogen or an amino group, R'2 =H or a lower alkyl group. These compounds have antitumoral and antiviral properties useful for the treatment of cancers.

Photocyclization of 1-(1-Chloroisoquinolin-6-yl)-1H-v-triazolopyridines to 10-Chloro-5H-pyridopyrroloisoquinolines (Azaellipticines)

Whereas thermal cyclization of 1-(5,8-dimethyl-1-oxo-1,2-dihydroisoquinolin-6-yl)-1H-v-triazolopyridine affords 6,11-dimethyl-5H-pyridopyrroloisoquinolin-10(9H)-one which cannot be chlorinated to the corresponding chloro derivativ